(Q40046116)

16 September 2017

title

Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells (English)

1 reference

16 September 2017

1 reference

5

Nanshan Zhong

1 reference

16 September 2017

6

Pixin Ran

1 reference

16 September 2017

Zhiyi He

1

1 reference

16 September 2017

Bing Li

series ordinal

2

1 reference

16 September 2017

Liang Yu

series ordinal

3

1 reference

16 September 2017

Qicai Liu

series ordinal

4

1 reference

16 September 2017

publication date

21 November 2007

1 reference

16 September 2017

1 reference

16 September 2017

volume

75

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

202-209

1 reference

Macrolides for the treatment of chronic sinusitis, asthma, and COPD.

16 September 2017

cites work

1 reference

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease

21 January 2018

1 reference

The effects of macrolides on inflammatory cells

21 January 2018

1 reference

Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

21 January 2018

1 reference

Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells

21 January 2018

1 reference

Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells

21 January 2018

1 reference

Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells

21 January 2018

1 reference

Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors

21 January 2018

1 reference

The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial

21 January 2018

1 reference

The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data

21 January 2018

1 reference

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.

21 January 2018

1 reference

The role of oxidative stress in the pathogenesis of COPD: implications for therapy

21 January 2018

1 reference

Gender and chronic obstructive pulmonary disease in high-risk smokers.

21 January 2018

1 reference

Characterisation of gamma-glutamylcysteine synthetase-heavy subunit promoter: a critical role for AP-1.

21 January 2018

1 reference

Preferential localization of hyperphosphorylated replication protein A to double-strand break repair and checkpoint complexes upon DNA damage

21 January 2018

1 reference

Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease

21 January 2018

1 reference

Glutathione deficiency and human immunodeficiency virus infection

21 January 2018

1 reference

Quantification of mitogen induced human lymphocyte proliferation: comparison of alamarBlue assay to 3H-thymidine incorporation assay

21 January 2018

1 reference

Diffuse panbronchiolitis: role of macrolides in therapy

21 January 2018

1 reference

Oxidants/antioxidants and COPD.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000111569

1 reference

16 September 2017

1 reference